The association of wild-type ADAR3 with dsRNA structures can influence the editing efficacy of ADAR2, as demonstrated by ADAR3’s suppression of GluR-B pre-mRNA editing in glioblastoma (GBM) cells (59). The gene discussed is ADARB2; the disease is glioblastoma.